Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VIVE

Viveve

$3.00

-0.11 (-3.54%)

08:31
09/11/18
09/11
08:31
09/11/18
08:31
Hot Stocks
Viveve submits IDE to FDA for LIBERATE-U.S. trial »

Viveve announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
VIVE

Viveve

$3.09

-0.13 (-4.04%)

11:55
08/23/18
08/23
11:55
08/23/18
11:55
Hot Stocks
Breaking Hot Stocks news story on Viveve »

Craig A. Drill reports 6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$2.80

0.185 (7.09%)

08:42
08/14/18
08/14
08:42
08/14/18
08:42
Hot Stocks
Viveve initiates LIBERATE-International trial for SUI »

Viveve announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$2.47

0.12 (5.11%)

16:14
08/09/18
08/09
16:14
08/09/18
16:14
Earnings
Viveve reports Q EPS (37c), consensus (38c) »

Reports Q2 revenue $5.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

VIVE

Viveve

$2.34

-0.24 (-9.30%)

08:29
08/07/18
08/07
08:29
08/07/18
08:29
Hot Stocks
Viveve announces FDA approval to continue VIVEVE II clinical study »

Viveve Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

VIVE

Viveve

$2.05

-0.44 (-17.67%)

05:52
07/31/18
07/31
05:52
07/31/18
05:52
Recommendations
Viveve analyst commentary at Mizuho »

Seven Viveve competitors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$2.31

-0.18 (-7.23%)

, HOLX

Hologic

$42.80

0.33 (0.78%)

15:13
07/30/18
07/30
15:13
07/30/18
15:13
Recommendations
Viveve, Hologic analyst commentary at Craig-Hallum »

FDA warning to off-label…

VIVE

Viveve

$2.31

-0.18 (-7.23%)

HOLX

Hologic

$42.80

0.33 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 14

    Aug

  • 15

    Aug

  • 27

    Aug

VIVE

Viveve

$2.30

-0.19 (-7.63%)

15:00
07/30/18
07/30
15:00
07/30/18
15:00
Hot Stocks
Viveve lower after FDA sends safety communication on vaginal 'rejuvenation' »

The FDA sent a safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$2.73

-0.13 (-4.55%)

06:15
07/11/18
07/11
06:15
07/11/18
06:15
Recommendations
Viveve analyst commentary at Mizuho »

Viveve Q2 results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$2.86

0.01 (0.35%)

08:36
07/10/18
07/10
08:36
07/10/18
08:36
Hot Stocks
Viveve partners with Aesthetic Management Partners to expand U.S. footprint »

Viveve Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.